You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Article info

Article menu

Download PDFPDF

Research Article
Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Authors

  • Yixin Zhou State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of VIP regionSun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Chen Chen State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of RadiotherapySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Xuanye Zhang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Sha Fu Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Pathology DepartmentSun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou China PubMed articlesGoogle scholar articles
  • Cong Xue State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Yuxiang Ma State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Wenfeng Fang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Yunpeng Yang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Xue Hou State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Yan Huang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Hongyun Zhao State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Shaodong Hong State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Li Zhang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles

Citation

Zhou Y, Chen C, Zhang X, et al
Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis
Journal for ImmunoTherapy of Cancer 2018;6:155. doi: 10.1186/s40425-018-0477-9
Online issue publication 
February 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.